E-Mail Study of 30,000 adults living with HIV receiving antiretroviral therapy (ART) in Latin America and the Caribbean finds life expectancy has increased to within 10 years of the general population in these countries over the last two decades. Disparities in life expectancy due to demographic and clinical factors at the point participants began ART (including sexual HIV transmission risk, low CD4 cell count, and history of tuberculosis) highlight an ongoing need to reach vulnerable populations in the region.
Life expectancy among adults living with HIV receiving antiretroviral therapy (ART) in Latin America and the Caribbean has increased significantly since HIV testing and treatment services became more widely available, according to research published today in
U.S. Sen. Jon Ossoff has been named keynote speaker for Emory University’s Class Day, a student-organized event for students receiving bachelor’s degrees at this year’s Commencement.
The program will be held virtually Thursday, May 14, at 6:30 p.m. on the Emory Commencement website.
“The Class Day committee is thrilled to welcome Sen. Jon Ossoff to campus for Class Day 2021,” says Liz Greene, a senior political science and media studies major from Charlotte, North Carolina. “During the landmark 2021 Georgia Senate run-offs, Emory students practiced a high level of civic engagement through campaigning, activism and voter drives. Ossoff’s belief in young people as change makers is especially relevant as members of the Class of 2021 leave Emory and go on to impact new communities. We’re incredibly excited to hear his wisdom and advice to the parting class.”
The drug discovery engine is eyeing future partnerships after securing deals with Sanofi and Indivior
The firm aims to create the world s most productive drug discovery engine by designing small-molecule medicines that can be easily delivered to the affected area of the patient’s body.
“We don t plan to become a clinical company and we remain in the early phase, and the reason for that is we have a couple of very good technologies which we believe make a big difference in that phase and differentiates us from the rest,” chief executive Clive Dix told Proactive.
“We plan to always have a portfolio of projects that we work on using our technologies to find really good molecules, high-quality molecules, which we take anywhere from starting point all the way through to a clinical candidate ready to go in the clinic.”
SARS-CoV-2 pandemic underscores importance of understanding evolution of RNA genomes news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.